Cargando…

Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study

PURPOSE: To evaluate intensity-modulated radiation therapy (IMRT) as an alternative to conformal radiotherapy (CRT) or 4-field box boost (4FB) in women with gynecologic malignancies who are unsuitable for brachytherapy for technical or medical reasons. METHODS: Dosimetric and toxicity information wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Philip, Yeo, Inhwan, Perkins, Gregory, Fyles, Anthony, Milosevic, Michael
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1471795/
https://www.ncbi.nlm.nih.gov/pubmed/16722546
http://dx.doi.org/10.1186/1748-717X-1-13
_version_ 1782127836101869568
author Chan, Philip
Yeo, Inhwan
Perkins, Gregory
Fyles, Anthony
Milosevic, Michael
author_facet Chan, Philip
Yeo, Inhwan
Perkins, Gregory
Fyles, Anthony
Milosevic, Michael
author_sort Chan, Philip
collection PubMed
description PURPOSE: To evaluate intensity-modulated radiation therapy (IMRT) as an alternative to conformal radiotherapy (CRT) or 4-field box boost (4FB) in women with gynecologic malignancies who are unsuitable for brachytherapy for technical or medical reasons. METHODS: Dosimetric and toxicity information was analyzed for 12 patients with cervical (8), endometrial (2) or vaginal (2) cancer previously treated with external beam pelvic radiotherapy and a CRT boost. Optimized IMRT boost treatment plans were then developed for each of the 12 patients and compared to CRT and 4FB plans. The plans were compared in terms of dose conformality and critical normal tissue avoidance. RESULTS: The median planning target volume (PTV) was 151 cm(3 )(range 58–512 cm(3)). The median overlap of the contoured rectum with the PTV was 15 (1–56) %, and 11 (4–35) % for the bladder. Two of the 12 patients, both with large PTVs and large overlap of the contoured rectum and PTV, developed grade 3 rectal bleeding. The dose conformity was significantly improved with IMRT over CRT and 4FB (p ≤ 0.001 for both). IMRT also yielded an overall improvement in the rectal and bladder dose-volume distributions relative to CRT and 4FB. The volume of rectum that received the highest doses (>66% of the prescription) was reduced by 22% (p < 0.001) with IMRT relative to 4FB, and the bladder volume was reduced by 19% (p < 0.001). This was at the expense of an increase in the volume of these organs receiving doses in the lowest range (<33%). CONCLUSION: These results indicate that IMRT can improve target coverage and reduce dose to critical structures in gynecologic patients receiving an external beam radiotherapy boost. This dosimetric advantage will be integrated with other patient and treatment-specific factors, particularly internal tumor movement during fractionated radiotherapy, in the context of a future image-guided radiation therapy study.
format Text
id pubmed-1471795
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-14717952006-05-27 Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study Chan, Philip Yeo, Inhwan Perkins, Gregory Fyles, Anthony Milosevic, Michael Radiat Oncol Research PURPOSE: To evaluate intensity-modulated radiation therapy (IMRT) as an alternative to conformal radiotherapy (CRT) or 4-field box boost (4FB) in women with gynecologic malignancies who are unsuitable for brachytherapy for technical or medical reasons. METHODS: Dosimetric and toxicity information was analyzed for 12 patients with cervical (8), endometrial (2) or vaginal (2) cancer previously treated with external beam pelvic radiotherapy and a CRT boost. Optimized IMRT boost treatment plans were then developed for each of the 12 patients and compared to CRT and 4FB plans. The plans were compared in terms of dose conformality and critical normal tissue avoidance. RESULTS: The median planning target volume (PTV) was 151 cm(3 )(range 58–512 cm(3)). The median overlap of the contoured rectum with the PTV was 15 (1–56) %, and 11 (4–35) % for the bladder. Two of the 12 patients, both with large PTVs and large overlap of the contoured rectum and PTV, developed grade 3 rectal bleeding. The dose conformity was significantly improved with IMRT over CRT and 4FB (p ≤ 0.001 for both). IMRT also yielded an overall improvement in the rectal and bladder dose-volume distributions relative to CRT and 4FB. The volume of rectum that received the highest doses (>66% of the prescription) was reduced by 22% (p < 0.001) with IMRT relative to 4FB, and the bladder volume was reduced by 19% (p < 0.001). This was at the expense of an increase in the volume of these organs receiving doses in the lowest range (<33%). CONCLUSION: These results indicate that IMRT can improve target coverage and reduce dose to critical structures in gynecologic patients receiving an external beam radiotherapy boost. This dosimetric advantage will be integrated with other patient and treatment-specific factors, particularly internal tumor movement during fractionated radiotherapy, in the context of a future image-guided radiation therapy study. BioMed Central 2006-05-04 /pmc/articles/PMC1471795/ /pubmed/16722546 http://dx.doi.org/10.1186/1748-717X-1-13 Text en Copyright © 2006 Chan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Chan, Philip
Yeo, Inhwan
Perkins, Gregory
Fyles, Anthony
Milosevic, Michael
Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study
title Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study
title_full Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study
title_fullStr Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study
title_full_unstemmed Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study
title_short Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study
title_sort dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1471795/
https://www.ncbi.nlm.nih.gov/pubmed/16722546
http://dx.doi.org/10.1186/1748-717X-1-13
work_keys_str_mv AT chanphilip dosimetriccomparisonofintensitymodulatedconformalandfourfieldpelvicradiotherapyboostplansforgynecologiccanceraretrospectiveplanningstudy
AT yeoinhwan dosimetriccomparisonofintensitymodulatedconformalandfourfieldpelvicradiotherapyboostplansforgynecologiccanceraretrospectiveplanningstudy
AT perkinsgregory dosimetriccomparisonofintensitymodulatedconformalandfourfieldpelvicradiotherapyboostplansforgynecologiccanceraretrospectiveplanningstudy
AT fylesanthony dosimetriccomparisonofintensitymodulatedconformalandfourfieldpelvicradiotherapyboostplansforgynecologiccanceraretrospectiveplanningstudy
AT milosevicmichael dosimetriccomparisonofintensitymodulatedconformalandfourfieldpelvicradiotherapyboostplansforgynecologiccanceraretrospectiveplanningstudy